Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po Hui Chiang

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
The Kaohsiung Journal of Medical Sciences|September 18, 2016
Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancerYuan-Chi Shen, Po-Hui Chiang, Hao-Lun Luo, et al.
Lasers in Surgery and Medicine|September 29, 2012
High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml)Chien-Hsu Chen, Po-Hui Chiang, Wei-Chia Lee, et al.
Scientific Reports|April 28, 2022
MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signalingYueh-Hua Chung, Yuan-Tso Cheng, Ying-Hsien Kao, et al.
Journal of Cancer|July 21, 2018
Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial CarcinomaMeng-Che Hsieh, Kun-Ming Rau, Po-Hui Chiang, et al.
Plos One|January 12, 2017
Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial CarcinomaYu-Li Su, Meng-Che Hsieh, Po-Hui Chiang, et al.
The Kaohsiung Journal of Medical Sciences|August 16, 2012
Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasiaThomas I S Hwang, Sheng-Hsien Chu, Mao-Sheng Lin, et al.
BJU International|May 20, 2011
Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Hong-Jeng Yu, Alex Tong-Long Lin, Stephen Shei-Dei Yang, et al.
Journal of Cancer Research and Therapeutics|February 13, 2014
Zoledronic acid treatment for cancerous bone metastases: a phase IV study in TaiwanPo-Hui Chiang, Hwei-Chung Wang, Yuen-Liang Lai, et al.
Frontiers in Oncology|December 19, 2022
The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: A large retrospective cohort studyYing-Che Huang, Hung-Jen Wang, Min-Tse Sung, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 27, 2020
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration CohortHao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
The Kaohsiung Journal of Medical Sciences|September 18, 2016
Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancerYuan-Chi Shen, Po-Hui Chiang, Hao-Lun Luo, et al.
Lasers in Surgery and Medicine|September 29, 2012
High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml)Chien-Hsu Chen, Po-Hui Chiang, Wei-Chia Lee, et al.
Scientific Reports|April 28, 2022
MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signalingYueh-Hua Chung, Yuan-Tso Cheng, Ying-Hsien Kao, et al.
Journal of Cancer|July 21, 2018
Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial CarcinomaMeng-Che Hsieh, Kun-Ming Rau, Po-Hui Chiang, et al.
Plos One|January 12, 2017
Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial CarcinomaYu-Li Su, Meng-Che Hsieh, Po-Hui Chiang, et al.
The Kaohsiung Journal of Medical Sciences|August 16, 2012
Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasiaThomas I S Hwang, Sheng-Hsien Chu, Mao-Sheng Lin, et al.
BJU International|May 20, 2011
Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Hong-Jeng Yu, Alex Tong-Long Lin, Stephen Shei-Dei Yang, et al.
Journal of Cancer Research and Therapeutics|February 13, 2014
Zoledronic acid treatment for cancerous bone metastases: a phase IV study in TaiwanPo-Hui Chiang, Hwei-Chung Wang, Yuen-Liang Lai, et al.
Frontiers in Oncology|December 19, 2022
The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: A large retrospective cohort studyYing-Che Huang, Hung-Jen Wang, Min-Tse Sung, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 27, 2020
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration CohortHao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, et al.
Pageof 12